Loading clinical trials...
Loading clinical trials...
Phase I Safety and Tolerability of Intravesical VAX014 for Instillation in Subjects With Non-Muscle Invasive Bladder Cancer (NMIBC)
Conditions
Interventions
VAX014
Locations
5
United States
The Urology Center of Colorado
Denver, Colorado, United States
University of Iowa Hospital and Clinics
Iowa City, Iowa, United States
New Jersey Urology, LLC.
Edison, New Jersey, United States
Carolina Urologic Research Center
Myrtle Beach, South Carolina, United States
Baylor College of Medicine
Houston, Texas, United States
Start Date
May 10, 2019
Primary Completion Date
March 1, 2023
Completion Date
March 1, 2023
Last Updated
March 3, 2023
Lead Sponsor
Vaxiion Therapeutics
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions